Skip to main content
Equibles
ISRG logo

ISRG · Intuitive Surgical Inc

Track ISRG — free

Use ISRG with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$366.70 -3.13 (-0.85%) At close · Sep 4
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$130.62B
Shares
353.28M

ISRG metrics

79 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$366.70
Market cap
$130.62B

Price action

19 metrics
Price change (1W)
+0.8%
Price change (30D)
-1.0%
Price change (3M)
-11.7%
Price change (6M)
-25.5%
Price change (YTD)
-34.7%
Price change (1Y)
-16.2%
Trailing year
Price change (5Y)
—
52-week high
$592.85
52-week low
$332.02
Change from 52-week high
-37.6%
Change from 52-week low
+11.4%
Annualized volatility
36.7%
Beta
1.0
RSI (14D)
44.8
Price vs SMA 50
-3.1%
Price vs SMA 200
-20.4%
Avg volume (3M)
2.99M
Relative volume
0.6
Average dollar volume
$1.14B

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
353.28M

Valuation

12 metrics
P / E (TTM)
42.5
Trailing earnings · reciprocal yield 2.4%
PEG ratio
1.6
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
11.8×
reciprocal yield 8.4%
P / book
7.2
reciprocal yield 13.9%
FCF yield
2.5%
TTM · current market cap
Buyback yield
2.7%
P / FCF
40.5
reciprocal yield 2.5%
P / operating cash flow
35.2
reciprocal yield 2.8%
Earnings yield
2.4%

Historical valuation

8 metrics
P / E historical average (3Y)
69.8×
reciprocal yield 1.4%
P / E historical average (5Y)
68.1×
reciprocal yield 1.5%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-16

Profitability

9 metrics
Gross margin
66.7%
Operating margin
31.3%
Trailing 12 months
Net margin
28.4%
Gross profit (TTM)
$7.36B
Operating profit (TTM)
$3.45B
Net income (TTM)
$3.14B
Trailing 12 months
Diluted EPS (TTM)
$8.71
FCF margin
29.2%
Effective tax rate
17.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$10.78

Growth

11 metrics
Revenue growth YoY
+18.5%
Year over year
Net income growth YoY
+24.3%
Revenue (TTM)
$11.03B
Trailing 12 months
EPS growth YoY
+26.5%
Shares change YoY
-1.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+17.4%
Revenue CAGR (5Y)
+18.2%
EPS CAGR (3Y)
+29.2%
EPS CAGR (5Y)
+21.8%
FCF CAGR (3Y)
+37.5%
FCF CAGR (5Y)
+16.9%

Quality

14 metrics
Return on equity
17.3%
Return on assets
15.0%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
—
Free cash flow (TTM)
$3.22B
Quick ratio
3.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$5.22B
Latest balance sheet
Cash & equivalents
$2.76B
Total assets
$20.88B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.71B
Capital expenditures (TTM)
$483.80M
R&D (TTM)
$1.41B
SG&A (TTM)
$2.49B
Stock compensation (TTM)
$826.20M
R&D / revenue
12.8%
Stock compensation / revenue
7.5%

Ownership (13F)

3 metrics
13F filers
2,240
13F filer change QoQ
-83
Institutional ownership
89.0%

Short interest

3 metrics
Short interest
2.0%
Latest settlement · 2.3 days to cover
Days to cover
2.3d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.75M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1035267 CUSIP 46120E602 13F (30d) 1162 filings 1097 filers Visit website Investor relations